… Clinical implications of plasma EpsteinBarr virus DNA in early-stage extranodal nasal-type
NK/T… Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific …

… Epstein-Barr virus (EBV; figure 1) has co-evolved with human beings over millions of years
and during this long association the virus life cycle has become supremely adapted to its …

… cell clone, therebypreventing evolution to a monoclonal lymphoma… The independent evolution
of these unregulated B-cell … clonal cytogeneticabnormalities suggests that evolution from a …

… It is more than 50 years since the Epstein–Barr virus (EBV), the first human tumour virus,
was … insights at the molecular level in the diagnosis, treatment and prevention of cancer. …

… treatment of cancers. Adoptive T-cell therapy has been successfully used in the prevention
and treatment … EBV reactivation, termed PTLD that can evolve into Hodgkin lymphoma or non-…

… , including drugs licensed for treatment of other herpesviruses, … EBV proteins, Epstein-Barr
nuclear antigens EBNA3, EBNA4 … But how they arise and evolve during primary EBV infection …

… In this sense, the initial treatment of EBV-HLH should be similar to the treatment of systemic
… , the treatment objective is to abrogate the inflammatory cascade. For this kind of treatment to …

Epstein-Barr virus (EBV) is a tumorigenic herpes virus that infects and persists in B
lymphocytes in the majority of humans, generally without causing disease. However, in a few …

… demonstrating a link between B cell-tropic Epstein–Barr virus (EBV) and disease onset.
Efforts to develop antiviral strategies for treating MS are underway. Although gaps remain in our …

… virus (EBV) is a ubiquitous pathogen that has evolved an effective strategy for infection, …
no clinical benefit in treating uncomplicated acute infectious mononucleosis with acyclovir. …